Zinc in PDB 5mat: Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor
Protein crystallography data
The structure of Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor, PDB code: 5mat
was solved by
S.Moniot,
C.Steegborn,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
44.89 /
2.07
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
59.683,
68.560,
78.462,
90.00,
95.66,
90.00
|
R / Rfree (%)
|
16.5 /
n/a
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor
(pdb code 5mat). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor, PDB code: 5mat:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 5mat
Go back to
Zinc Binding Sites List in 5mat
Zinc binding site 1 out
of 2 in the Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn401
b:19.3
occ:1.00
|
SG
|
A:CYS221
|
2.3
|
19.7
|
1.0
|
SG
|
A:CYS224
|
2.3
|
21.7
|
1.0
|
SG
|
A:CYS195
|
2.4
|
19.8
|
1.0
|
SG
|
A:CYS200
|
2.4
|
23.8
|
1.0
|
HB3
|
A:CYS200
|
2.9
|
30.4
|
1.0
|
HB3
|
A:CYS221
|
3.1
|
22.4
|
1.0
|
CB
|
A:CYS221
|
3.1
|
18.7
|
1.0
|
HB2
|
A:CYS195
|
3.1
|
24.1
|
1.0
|
CB
|
A:CYS200
|
3.1
|
25.4
|
1.0
|
HB2
|
A:CYS221
|
3.1
|
22.4
|
1.0
|
CB
|
A:CYS195
|
3.2
|
20.1
|
1.0
|
H
|
A:CYS224
|
3.3
|
28.1
|
1.0
|
HB3
|
A:CYS195
|
3.3
|
24.1
|
1.0
|
HB2
|
A:CYS200
|
3.4
|
30.4
|
1.0
|
HB3
|
A:CYS224
|
3.5
|
27.1
|
1.0
|
CB
|
A:CYS224
|
3.6
|
22.6
|
1.0
|
HB2
|
A:ASP223
|
3.6
|
35.7
|
1.0
|
HB2
|
A:SER226
|
3.7
|
26.7
|
1.0
|
H
|
A:HIS202
|
3.8
|
26.9
|
1.0
|
N
|
A:CYS224
|
3.9
|
23.4
|
1.0
|
HB3
|
A:SER197
|
3.9
|
31.8
|
1.0
|
H
|
A:SER226
|
4.0
|
27.2
|
1.0
|
HB2
|
A:HIS202
|
4.1
|
32.2
|
1.0
|
HB3
|
A:HIS202
|
4.1
|
32.2
|
1.0
|
H
|
A:ARG201
|
4.1
|
30.6
|
1.0
|
CA
|
A:CYS224
|
4.3
|
22.7
|
1.0
|
HB2
|
A:CYS224
|
4.3
|
27.1
|
1.0
|
H
|
A:ASP223
|
4.4
|
29.1
|
1.0
|
CA
|
A:CYS200
|
4.5
|
26.5
|
1.0
|
CB
|
A:HIS202
|
4.5
|
26.9
|
1.0
|
CB
|
A:ASP223
|
4.6
|
29.8
|
1.0
|
CA
|
A:CYS221
|
4.6
|
22.6
|
1.0
|
N
|
A:ARG201
|
4.6
|
25.5
|
1.0
|
CB
|
A:SER226
|
4.6
|
22.2
|
1.0
|
HH
|
A:TYR204
|
4.6
|
29.8
|
1.0
|
CA
|
A:CYS195
|
4.7
|
21.0
|
1.0
|
O
|
A:HOH573
|
4.7
|
28.0
|
1.0
|
N
|
A:HIS202
|
4.7
|
22.4
|
1.0
|
H
|
A:GLN225
|
4.7
|
27.6
|
1.0
|
H
|
A:SER197
|
4.7
|
31.7
|
1.0
|
HG
|
A:SER226
|
4.8
|
28.0
|
1.0
|
C
|
A:CYS224
|
4.8
|
22.7
|
1.0
|
N
|
A:SER226
|
4.8
|
22.6
|
1.0
|
CB
|
A:SER197
|
4.8
|
26.5
|
1.0
|
C
|
A:CYS200
|
4.8
|
26.4
|
1.0
|
HB3
|
A:ASP223
|
4.8
|
35.7
|
1.0
|
C
|
A:ASP223
|
4.9
|
25.5
|
1.0
|
HA
|
A:CYS221
|
4.9
|
27.1
|
1.0
|
N
|
A:GLN225
|
4.9
|
23.0
|
1.0
|
HA
|
A:CYS195
|
4.9
|
25.2
|
1.0
|
HB2
|
A:SER197
|
5.0
|
31.8
|
1.0
|
|
Zinc binding site 2 out
of 2 in 5mat
Go back to
Zinc Binding Sites List in 5mat
Zinc binding site 2 out
of 2 in the Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Structure of Human Sirtuin 2 in Complex with A Selective Thienopyrimidinone Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn401
b:65.0
occ:1.00
|
SG
|
C:CYS200
|
2.2
|
66.8
|
1.0
|
SG
|
C:CYS195
|
2.4
|
65.3
|
1.0
|
SG
|
C:CYS221
|
2.5
|
55.2
|
1.0
|
SG
|
C:CYS224
|
2.5
|
60.7
|
1.0
|
HB3
|
C:CYS200
|
2.6
|
96.6
|
1.0
|
CB
|
C:CYS200
|
2.8
|
80.5
|
1.0
|
HB2
|
C:CYS221
|
3.0
|
66.5
|
1.0
|
HB2
|
C:CYS195
|
3.0
|
73.3
|
1.0
|
HB2
|
C:CYS200
|
3.0
|
96.6
|
1.0
|
HB3
|
C:CYS221
|
3.0
|
66.5
|
1.0
|
CB
|
C:CYS221
|
3.1
|
55.4
|
1.0
|
CB
|
C:CYS195
|
3.1
|
61.1
|
1.0
|
HB3
|
C:CYS195
|
3.1
|
73.3
|
1.0
|
H
|
C:CYS224
|
3.5
|
85.5
|
1.0
|
HB2
|
C:ASP223
|
3.6
|
90.5
|
1.0
|
HB3
|
C:CYS224
|
3.7
|
80.2
|
1.0
|
CB
|
C:CYS224
|
3.7
|
66.8
|
1.0
|
H
|
C:HIS202
|
3.8
|
82.7
|
1.0
|
HB3
|
C:SER197
|
3.9
|
72.3
|
1.0
|
HB2
|
C:HIS202
|
3.9
|
89.8
|
1.0
|
HB3
|
C:SER226
|
4.0
|
80.4
|
1.0
|
HB3
|
C:HIS202
|
4.0
|
89.8
|
1.0
|
N
|
C:CYS224
|
4.1
|
71.2
|
1.0
|
H
|
C:SER226
|
4.2
|
75.9
|
1.0
|
H
|
C:ARG201
|
4.3
|
84.5
|
1.0
|
CA
|
C:CYS200
|
4.3
|
79.1
|
1.0
|
CB
|
C:HIS202
|
4.4
|
74.9
|
1.0
|
CA
|
C:CYS224
|
4.4
|
69.4
|
1.0
|
H
|
C:ASP223
|
4.5
|
84.2
|
1.0
|
HB2
|
C:CYS224
|
4.5
|
80.2
|
1.0
|
CB
|
C:ASP223
|
4.6
|
75.5
|
1.0
|
HH
|
C:TYR204
|
4.6
|
68.1
|
1.0
|
CA
|
C:CYS221
|
4.6
|
55.9
|
1.0
|
CA
|
C:CYS195
|
4.6
|
57.2
|
1.0
|
N
|
C:HIS202
|
4.6
|
68.9
|
1.0
|
N
|
C:ARG201
|
4.6
|
70.4
|
1.0
|
HA
|
C:CYS200
|
4.7
|
94.9
|
1.0
|
C
|
C:CYS200
|
4.7
|
75.2
|
1.0
|
CB
|
C:SER226
|
4.8
|
67.0
|
1.0
|
H
|
C:GLN225
|
4.8
|
81.0
|
0.6
|
H
|
C:GLN225
|
4.8
|
81.0
|
0.4
|
CB
|
C:SER197
|
4.8
|
60.2
|
1.0
|
HB2
|
C:SER226
|
4.9
|
80.4
|
1.0
|
HA
|
C:CYS221
|
4.9
|
67.1
|
1.0
|
HB3
|
C:ASP223
|
4.9
|
90.5
|
1.0
|
HA
|
C:CYS195
|
4.9
|
68.7
|
1.0
|
HE2
|
C:TYR204
|
4.9
|
62.1
|
1.0
|
H
|
C:SER197
|
4.9
|
73.4
|
1.0
|
C
|
C:ASP223
|
5.0
|
73.7
|
1.0
|
C
|
C:CYS224
|
5.0
|
68.2
|
1.0
|
N
|
C:SER226
|
5.0
|
63.3
|
1.0
|
|
Reference:
S.Sundriyal,
S.Moniot,
Z.Mahmud,
S.Yao,
P.Di Fruscia,
C.R.Reynolds,
D.T.Dexter,
M.J.Sternberg,
E.W.Lam,
C.Steegborn,
M.J.Fuchter.
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket. J. Med. Chem. V. 60 1928 2017.
ISSN: ISSN 1520-4804
PubMed: 28135086
DOI: 10.1021/ACS.JMEDCHEM.6B01690
Page generated: Sun Oct 27 22:03:24 2024
|